Insiders Haemonetics Corporation

Equities

Market Closed - Nyse Other stock markets 01:30:02 08/05/2024 am IST			5-day change	1st Jan Change
95.2 ^USD	-0.19%		+3.53%	+11.33%

04/04	Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge	MT
04/04	Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge	CI

Haemonetics Insider Sold Shares Worth $207,450, According to a Recent SEC Filing	14/23/14	MT
Insider Sell: Haemonetics	08/23/08	MT
Haemonetics Corporation Elects Diane M. Bryant to Its Board of Directors	08/23/08	CI
Insider Sell: Haemonetics	21/23/21	MT
Insider Sell: Haemonetics	10/23/10	MT
Insider Sell: Haemonetics	26/23/26	MT
ViewRay Reports Higher Preliminary Q4 Revenue; Appoints William Burke as CFO	09/23/09	MT
Haemonetics Corporation Appoints Maryanne Farris as Principal Accounting Officer	20/22/20	CI
Former Medtronic Executive Joins Haemonetics as President of Global Plasma, Blood Center	04/22/04	MT
Haemonetics Appoints Roy Galvin as President, Global Plasma and Blood Center	04/22/04	CI
Insider Sell: Haemonetics	22/22/22	MT
Insider Sell: Haemonetics	17/22/17	MT
Haemonetics Corporation Announces Management Changes	09/22/09	CI
Haemonetics Corporation Announces Michelle L. Basil, Executive Vice President, General Counsel Has Decided to Transition, Effective October 31, 2022	17/22/17	CI
Haemonetics Corporation Announces Retirement of Dan Goldstein as Vice President, Corporate Controller and Principal Accounting Officer, Effective August 9, 2022	25/22/25	CI
Insider Sell: Haemonetics	24/22/24	MT
Insider Sell: Haemonetics	24/22/24	MT
Haemonetics Appoints James D'Arecca as Chief Financial Officer	22/22/22	MT
Haemonetics Names New Chief Financial Officer; Incumbent Retiring	22/22/22	MT
Haemonetics Announces Executive Changes	22/22/22	CI

No results for this search